Valneva SE

AYJ

Company Profile

  • Business description

    Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

  • Contact

    6 Rue Alain Bombard
    Saint-Herblain44800
    FRA

    T: +33 228073710

    E: investors.relations@vivalis.com

    https://www.valneva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    713

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,631.5042.700.50%
CAC 407,826.791.34-0.02%
DAX 4024,226.49198.840.83%
Dow JONES (US)42,343.65740.581.78%
FTSE 1008,778.0560.080.69%
HKSE23,381.9999.660.43%
NASDAQ19,199.16461.962.47%
Nikkei 22537,724.11192.580.51%
NZX 50 Index12,531.3051.03-0.41%
S&P 5005,921.54118.722.05%
S&P/ASX 2008,407.6046.600.56%
SSE Composite Index3,340.696.15-0.18%

Market Movers